Molina Healthcare (MOH) investor relations material

Strategic Outlook and Growth Plans

• Premium revenue is targeted to grow from $42 billion to $64 billion by 2029, representing a 15% CAGR, with half of this growth already secured through contract backlog and embedded revenue.

• Growth will come from a balanced mix of organic expansion, new contract wins, and M&A, with $6 billion in embedded revenue, $6 billion from initiatives, and $4 billion from acquisitions.

• Medicaid is projected to grow organically at 12%-14% CAGR, Medicare duals at 10%-14%, and Marketplace at 5% with optionality until risk pools stabilize.

• New state RFPs represent a $90 billion market opportunity by 2029, with a historical win rate of 80%.

• The company maintains a disciplined approach to capital deployment, prioritizing organic growth, accretive acquisitions, and share repurchases, supported by a strong balance sheet and ample capital.

Financial Guidance and Margin Recovery

• 2029 targets include $64 billion premium revenue, 15% CAGR, and adjusted EPS of $25, with consolidated MCR of 91%-92% and adjusted pretax margin of 2%-3%.

• 2026 guidance is reaffirmed at $5 EPS, with significant embedded earnings expected to be realized in 2027.

• Margin recovery is planned through rate improvements, fixed cost leverage, and operational discipline, requiring only 90 basis points of improvement versus 300 basis points needed by the broader market.

• G&A ratio is targeted to fall below 6% from 6.4%, driven by 50 basis points of efficiency gains, with additional upside from AI-driven cost savings not yet included in forecasts.

• Embedded earnings of $9 per share are identified, with $4.50 expected to be realized in the next year or by 2027, primarily from Florida CMS, MAPD exit, and operating leverage.

Operational Differentiation and Risk Management

• Sustained outperformance in MCR (200 basis points better than peers) is attributed to disciplined medical cost management, a unified operating platform, and a culture of performance.

• The company leverages best-in-class behavioral health management, payment integrity, and centralized clinical operations to maintain its margin advantage.

• Value-based care initiatives are being expanded, especially in Medicaid, to meet compliance and business objectives.

• AI adoption is underway, expected to deliver 100-150 basis points of additional cost savings over the next few years, with early results already visible in some operations.

• The management team emphasizes a flat, disciplined organizational structure and a proven track record of integrating acquisitions and driving operational excellence.